Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Virology Journal
Published in: Virology Journal 1/2009

Open Access 01-12-2009 | Short report

Seropositivity of Hepatitis B virus and Hepatitis C virus dual Infection among blood donors in Nyala Teaching Hospital

Authors: Mustafa Abdalla Ali Abou, Yassir Mohammed Eltahir

Published in: Virology Journal | Issue 1/2009

Login to get access

Abstract

The aim of this study was to determine the seropositivity of Hepatitis B virus (HBV) and Hepatitis C virus (HCV) dual infection among blood donors in Nyala Teaching Hospital, which is the biggest (400 beds) hospital in great Dar Fur of Western Sudan. 400 blood donors were tested serologically for the detection of HBsAg and anti-HCV antibodies. Only one (0.25%) out of the 400 examined blood donors was detected reactive for both HBsAg and anti-HCV antibodies. The study concluded that the seropositivity of HBV and HCV dual infection among population studied is uncommon.
Literature
1.
Devi KS, Singh NB, Mara J, Singh TB, Singh YM: Seroprevalence of Hepatitis B virus and Hepatitis C virus among hepatic disorders and injecting users in Manipur-A preliminary report. Indian Journal of Medical Microbiology 2004,22(2):136-137.PubMed
2.
Pallas JR, Farinas-Alvarez C, Prieto D, Delgado-Rodriguez M: Coinfection by HIV, Hepatitis B and Hepatitis C in imprisoned injecting drug users. Europe Journal of Epidemiology 1999, 15: 699-704. 10.1023/A:1007619614350CrossRef
3.
Reddy GA, Dakshinamurthy KV, Neelaprasad P, Gangadhar T, Lakshmi V: Prevalence of HBV and HCV dual infection in patients on hemodialysis. Indian Journal of Medical Microbiology 2005, 23: 41-43. 10.4103/0255-0857.13872CrossRefPubMed
4.
Aroldi A, Lampertico P, Montagnino G, Passerini P, Villa M, Campise MR, Lunghi G, Tarantino A, Cesana BM, Messa PG, Ponticelli C: Natural history of Hepatitis B and C in renal allograft recipients. Transplantation 2005, 79: 1132-1136. 10.1097/01.TP.0000161250.83392.73CrossRefPubMed
5.
Kalinowska-Nowak A, Bociaga-Jasik M, Garlicki A, Skwara P: Prevalence of hepatotropic viruses HBV and HCV in HIV-infected patients from Southern region of Poland. Acta virologica 2000, 44: 23-28.
6.
Irshad M, Peter S: Spectrum of viral hepatitis in thalassemic children receiving multiple blood transfusions. Indian Journal of Gastroenterology 2002, 21: 183-184.PubMed
7.
Liaw YF: Hepatitis C virus superinfection in patients with chronic Hepatitis B virus infection. Journal of Gastroenterology 2002, 37: 65-68. 10.1007/BF02990102CrossRefPubMed
8.
Ayoola EA, Gadour MO: Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection. Journal of Gastroenterology and Hepatology 2004, 19: 665-669. 10.1111/j.1440-1746.2003.03334.xCrossRefPubMed
9.
Castillo I, Rodriguez-Inigo E, Lopez-Alcorocho JM, Bartolome J, Pardo M, Carreno V: Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection. Journal of Medical Virology 2007, 79: 236-241. 10.1002/jmv.20784CrossRefPubMed
10.
Liu Z, Hou J: Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection. International Journal of Medical Science 2006, 3: 57-62.CrossRef
11.
Shi J, Zhu L, Liu S, Xie WF: A meta-analysis of case control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. British Journal of Cancer 2005, 92: 607-612. 10.1038/sj.bjc.6602460PubMedCentralCrossRefPubMed
12.
Crespo J, Lozano JL, de la Cruz F, Rodrigo L, Rodriguez M, San-Miguel G, ArtiSano E, Pons-Romero F: Prevalence and significance of hepatitis C viremia in chronic active hepatitis B. American Journal of Gastroenterology 1994, 89: 1147-1151.PubMed
13.
Fattovich G, Tagger A, Brollo L, Giustina G, Pontisso P, Realdi G, Alberti A, Ruol A: Hepatitis C virus infection in chronic hepatitis B virus carriers. Journal of Infectious Diseases 1991, 163: 400-402.CrossRefPubMed
14.
Abou MA, Eltahir YM, Ali AS: Seroprevalence of Hepatitis B virus and Hepatitis C virus among blood donors in Nyala, South Dar Fur, Sudan. Virology Journal 2009, 6: 146. 10.1186/1743-422X-6-146PubMedCentralCrossRefPubMed
15.
Nagi AM, Altyeb HA, Ahmed AM: Seroprevalence of Hepatitis B and C Viral Infections among blood donors in Shendi, River Nile State, Sudan. Research Journal of Medicine and Medical Sciences 2007,2(2):122-126.
Metadata
Title
Seropositivity of Hepatitis B virus and Hepatitis C virus dual Infection among blood donors in Nyala Teaching Hospital
Authors
Mustafa Abdalla Ali Abou
Yassir Mohammed Eltahir
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2009
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-6-227

Other articles of this Issue 1/2009

Virology Journal 1/2009 Go to the issue

Research

Intrinsic disorder in Viral Proteins Genome-Linked: experimental and predictive analyses

Research

Enhanced detection and study of murine norovirus-1 using a more efficient microglial cell line

Research

Enhanced anti-HCV activity of interferon alpha 17 subtype

Research

Partial direct contact transmission in ferrets of a mallard H7N3 influenza virus with typical avian-like receptor specificity

Research

Evidence of recombination in Hepatitis C Virus populations infecting a hemophiliac patient

Research

In vitro dynamics of HIV-1 BF intersubtype recombinants genomic regions involved in the regulation of gene expression
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits